Context :
Recently, UK pharmaceutical giant AstraZeneca has acknowledged that its Covid-19 vaccine can lead to a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).
More on News :
- The acknowledgement by AstraZeneca, in collaboration with the University of Oxford, comes amidst a lawsuit alleging severe harm and deaths caused by the vaccine.
- Kate, wife of a victim, demands an apology and fair compensation after a three-year struggle.
- The lawsuit, involving fifty-one cases, seeks around £100 million in compensation.
- In 2023, the World Health Organization (WHO) reported that Thrombosis with Thrombocytopenia Syndrome (TTS) emerged as a new adverse event following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus vector-based vaccines.
- This includes the AstraZeneca COVID-19 ChAdOx-1 vaccine and the Johnson & Johnson (J&J) Janssen COVID-19 Ad26.COV2-S vaccines.
What is TTS (Thrombosis with Thrombocytopenia Syndrome)?
- Thrombosis with Thrombocytopenia Syndrome (TTS) is an extremely rare condition characterized by the formation of blood clots (thrombosis) and low platelet counts (thrombocytopenia).
- It is also known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
- Thrombosis occurs when a blood clot forms in a blood vessel, which can impede blood flow.
- Thrombocytopenia is a condition where there is a low count of platelets in the blood.
- Platelets play a crucial role in clotting, which helps prevent excessive bleeding.
Vaccine Developed By AstraZeneca
About Covidshield :
- Covishield is not based on the mRNA platform but rather on the viral vector platform which utilizes a modified chimpanzee adenovirus, ChAdOx1, to deliver the COVID-19 spike protein into human cells.
- While this cold virus cannot infect the recipient, it can effectively instruct the immune system to prepare defenses against similar viruses.
|
- TTS is classified into 2 tiers by the CDC.
- Tier 1 :
- Rare blood clots, like in the brain or gut, sometimes alongside more typical ones in the legs or lungs.
- Low platelet count (below 150,000 per microliter).
- Tier 1 cases are usually more severe and riskier.
- This is more common in younger people.
- Tier 2 :
- Common blood clots, like in the legs or lungs.
- Low platelet count (below 150,000 per microliter). A positive anti-PF4 ELISA test is necessary for diagnosis.
Symptoms of TTS : It may include :
- Severe or persistent headaches,
- Blurred vision,
- Shortness of breath,
- Chest pain,
- Leg swelling,
- Persistent abdominal pain,
- confusion or seizure,
- Easy bruising or tiny blood spots under the skin beyond the injection site.
What is the link between TTS and the Covid vaccine?
- The link between TTS and the AstraZeneca Covid-19 vaccine was discovered after the vaccine’s rollout. Researchers found a connection between the vaccine and VITT.
- VITT is a subset of TTS, a distinction that AstraZeneca does not appear to acknowledge.
Additional Reading : Mission Covid Suraksha